|
PTGER4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.668000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.264800E-01 |
| Normal-vs-Stage2 |
2.044000E-03 |
| Normal-vs-Stage3 |
3.785800E-02 |
| Normal-vs-Stage4 |
1.590310E-02 |
| Stage1-vs-Stage2 |
2.105500E-02 |
| Stage1-vs-Stage3 |
2.074000E-01 |
| Stage1-vs-Stage4 |
7.911500E-02 |
| Stage2-vs-Stage3 |
9.761700E-02 |
| Stage2-vs-Stage4 |
2.832200E-01 |
| Stage3-vs-Stage4 |
5.791200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.589800E-02 |
| Normal-vs-AfricanAmerican |
8.144200E-01 |
| Normal-vs-Asian |
8.456000E-01 |
| Caucasian-vs-AfricanAmerican |
5.976000E-01 |
| Caucasian-vs-Asian |
9.672100E-02 |
| AfricanAmerican-vs-Asian |
7.436200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.631160E-01 |
| Normal-vs-Female |
5.494300E-02 |
| Male-vs-Female |
6.351800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.956400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.086300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.041290E-03 |
| Normal-vs-Age(81-100Yrs) |
6.233800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.631160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.201930E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.117800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.161000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.729410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.188200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.164300E-02 |
| Classical-VS-Follicular |
2.323900E-02 |
| Classical-VS-Other |
7.790400E-01 |
| Classical-VS-Normal |
1.993960E-01 |
| Tall-VS-Follicular |
5.570000E-01 |
| Tall-VS-Other |
5.313800E-01 |
| Tall-VS-Normal |
6.000000E-03 |
| Follicular-VS-Other |
2.898000E-01 |
| Follicular-VS-Normal |
5.260800E-03 |
| Other-VS-Normal |
9.931600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.853600E-02 |
| Normal-vs-N1 |
2.309000E-01 |
| N0-vs-N1 |
4.506200E-01 |
|
|
